Arkolith/Insider Trading/AIM/Form 4

Mitchell William M

DirectorAIM ImmunoTech Inc. (AIM) · full profile →Form 4 · filed Dec 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$870
Net Open-Market Flow
-$870
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2024Sell(S)5K$0.19$870119K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-051073) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML